Digital health took a huge technological step forward in 2020 due to the pandemic. Even traditionally less tech savvy patients now rely on digital products and services to manage their health including televisits, smart watches, online prescription refills, and connected fitness equipment. As we see the light at the end of the COVID tunnel, we discuss how life sciences companies can embrace the acceleration in digital health and adapt their plans to capitalize on the growth opportunities it presents including transforming business and operating models.
What will you learn?
- How COVID-19 has accelerated the adoption rate and expectations around digital health
- How to position your organization and operating model to get ahead of digital disruption
- Strategies and examples for driving disruption inside established life sciences companies
- What you can do as a leader to drive change
Watch the webinar now to hear the discussion between Scott Snyder, Founder of Mobiquity and Senior Fellow of The Wharton School; Celine Martin, Head of Digital Surgery at J&J Medical Device; James Kugler, CDO of Merck KGaA; and Cris De Luca, Global Head of Digital Investments at Sanofi Ventures.
